This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2009
Title: George Tien-San Lee: Innovator in Pharmaceutical Compounds
Introduction
George Tien-San Lee is a notable inventor based in Towaco, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing compounds that have the potential to treat various medical conditions.
Latest Patents
Lee's latest patents include a process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates. This invention is directed towards creating intermediates useful for synthesizing antibacterial N-formyl hydroxylamine compounds, which act as peptide deformylase inhibitors. The process utilizes an αβ-lactam intermediate and claims certain optically pure intermediates. Another significant patent involves heterocyclic compounds and methods of use, which provide pharmacological agents that are potent agonists of Peroxisome Proliferator-Activated Receptors (PPARs). These compounds are particularly useful in treating conditions such as dyslipidemia, hyperlipidemia, and various diseases related to PPAR receptor activity, including diabetes and cardiovascular diseases.
Career Highlights
George Tien-San Lee is currently employed at Novartis AG, where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment of numerous health conditions, showcasing his dedication to advancing medical science.
Collaborations
Lee collaborates with esteemed colleagues, including Prasad Koteswara Kapa and Xinglong Jiang. Their combined expertise contributes to the development of groundbreaking pharmaceutical solutions.
Conclusion
George Tien-San Lee is a prominent inventor whose work in pharmaceutical compounds is paving the way for innovative treatments. His contributions are vital in addressing significant health challenges faced by many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
